Search research articles
Contact Us
Filters
Showing results (31-40 of 60) with videos related to
Page
of 6
Sort By:
Advances in Experimental Medicine and Biology
|
January 1, 1995
Immune tolerance to Factor VIII: the international registry data
G Mariani, M Hilgartner, A R Thompson, et al.
British Journal of Haematology
|
January 29, 2000
The prothrombin Denver patient has two different prothrombin point mutations resulting in Glu-300-->Lys and Glu-309-->Lys substitutions
J B Lefkowitz, T Haver, S Clarke, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 23, 2003
Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study
G Young, M Manco-Johnson, J C Gill, et al.
Kidney International
|
April 1, 1987
Autosomal dominant polycystic kidney disease in childhood: a longitudinal study
A Sedman, P Bell, M Manco-Johnson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 3, 2000
MRI findings in haemophilic joints treated with radiosynoviorthesis with development of an MRI scale of joint damage
R Nuss, R F Kilcoyne, S Geraghty, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 22, 2011
Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand's disease (VWD) has limited value in dosing for surgery
J Di Paola, S Lethagen, J Gill, et al.
The Journal of Pediatrics
|
September 1, 1993
Unsuspected varicella-zoster virus encephalitis in a child with acquired immunodeficiency syndrome
C C Silliman, D Tedder, J W Ogle, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 6, 2008
Influence of the factor II G20210A variant or the factor V G1691A mutation on symptomatic recurrent venous thromboembolism in children: an international multicenter cohort study
G Young, S Becker, C Düring, et al.
Kidney International
|
February 1, 1989
The clinical utility of renal concentrating capacity in polycystic kidney disease
P A Gabow, W D Kaehny, A M Johnson, et al.
Respiration Physiology
|
June 1, 1988
Usual clinical dose of acetazolamide does not alter cerebral blood flow velocity
S Y Huang, R E McCullough, R G McCullough, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 60) with videos related to
Sort By:
Page
of 6
Advances in Experimental Medicine and Biology
|
January 1, 1995
Immune tolerance to Factor VIII: the international registry data
G Mariani, M Hilgartner, A R Thompson, et al.
British Journal of Haematology
|
January 29, 2000
The prothrombin Denver patient has two different prothrombin point mutations resulting in Glu-300-->Lys and Glu-309-->Lys substitutions
J B Lefkowitz, T Haver, S Clarke, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 23, 2003
Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study
G Young, M Manco-Johnson, J C Gill, et al.
Kidney International
|
April 1, 1987
Autosomal dominant polycystic kidney disease in childhood: a longitudinal study
A Sedman, P Bell, M Manco-Johnson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 3, 2000
MRI findings in haemophilic joints treated with radiosynoviorthesis with development of an MRI scale of joint damage
R Nuss, R F Kilcoyne, S Geraghty, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 22, 2011
Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand's disease (VWD) has limited value in dosing for surgery
J Di Paola, S Lethagen, J Gill, et al.
The Journal of Pediatrics
|
September 1, 1993
Unsuspected varicella-zoster virus encephalitis in a child with acquired immunodeficiency syndrome
C C Silliman, D Tedder, J W Ogle, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 6, 2008
Influence of the factor II G20210A variant or the factor V G1691A mutation on symptomatic recurrent venous thromboembolism in children: an international multicenter cohort study
G Young, S Becker, C Düring, et al.
Kidney International
|
February 1, 1989
The clinical utility of renal concentrating capacity in polycystic kidney disease
P A Gabow, W D Kaehny, A M Johnson, et al.
Respiration Physiology
|
June 1, 1988
Usual clinical dose of acetazolamide does not alter cerebral blood flow velocity
S Y Huang, R E McCullough, R G McCullough, et al.
Page
of 6